2020
DOI: 10.1038/s41541-020-00225-z
|View full text |Cite
|
Sign up to set email alerts
|

Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine

Abstract: This brief communication describes the findings from a randomised controlled trial in Vietnam that co-administration of measles vaccine (MV) with 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix®, GSK) does not affect the immunogenicity of MV. These findings are most relevant for low-and middle-income countries (LMICs) in Asia considering PCV introduction.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 9 publications
0
1
0
Order By: Relevance
“…Vietnam is a country with a high level of circulating measles. We have been running a routine vaccination program for children up to 18 months and several additional campaigns for an adolescent to decrease our number of patients [17,18]. Those attempts were rewarded with a high coverage rate of measles vac cine around 90%-95% between 2014 and 2018.…”
Section: The Number Of Measles Cases In Provinces Of Southern Vietnam...mentioning
confidence: 99%
“…Vietnam is a country with a high level of circulating measles. We have been running a routine vaccination program for children up to 18 months and several additional campaigns for an adolescent to decrease our number of patients [17,18]. Those attempts were rewarded with a high coverage rate of measles vac cine around 90%-95% between 2014 and 2018.…”
Section: The Number Of Measles Cases In Provinces Of Southern Vietnam...mentioning
confidence: 99%
“…We have previously reported that measles vaccine given at the same time as ten-valent pneumococcal conjugate vaccine (PCV10) at 9 months of age did not affect measles antibody titres. 36 Further studies are needed to understand the interaction between measles vaccine and other co-administered vaccines.…”
Section: Considerations For Early Measles Vaccinationmentioning
confidence: 99%